Why Choose Medvi?
With dozens of GLP-1 telehealth platforms now competing for patients, the obvious question is: what makes Medvi worth choosing over the alternatives? After 12 weeks of research and interviewing over 200 patients, we identified six clear reasons Medvi rises above the crowd.
Physician-Led Clinical Protocols
Every Medvi treatment plan is designed and overseen by board-certified physicians — not algorithms. Dosing decisions are made by humans who review your full health history, not automated decision trees.
Both Semaglutide & Tirzepatide Available
Most platforms offer only one option. Medvi gives patients and providers the flexibility to choose between semaglutide and the more potent dual-agonist tirzepatide based on individual needs.
Lab Work Built Into the Program
Core and Premium plans include at-home lab kits — metabolic panels, HbA1c, thyroid — giving providers the data they need to prescribe safely and personalize your protocol from day one.
503B Pharmacy Quality Standard
Medvi partners exclusively with FDA-registered 503B outsourcing facilities — the highest regulatory tier for compounding — and makes Certificates of Analysis available upon patient request.
Real Providers, Not Chatbots
Patient messages go directly to licensed clinical staff — not AI triage bots. Response times average 4–6 hours on weekdays, with 7-day availability on Core and Premium plans.
~78% Less Than Brand-Name Alternatives
Wegovy retails at $1,349/month. Medvi's Core plan starts at $299 — delivering medically equivalent compounded semaglutide at a fraction of the cost, with no hidden pharmacy markups.
Built for people who want results, not just a prescription.
Medvi's differentiation isn't just pricing — it's the combination of clinical rigor, medication flexibility, and genuine provider access that most telehealth platforms sacrifice in the race to scale cheaply.
See if Medvi's program is the right fit for you
Get started with a free eligibility assessment — takes less than 5 minutes.
What is Medvi?
Medvi is a direct-to-patient telehealth company specializing in GLP-1 receptor agonist therapy for weight management and metabolic health. Founded by a team of endocrinologists and digital health veterans, the platform connects patients with licensed healthcare providers who evaluate, prescribe, and monitor GLP-1 treatment — all without requiring an in-person clinic visit.
Unlike traditional weight-loss programs, Medvi positions itself squarely in the medically supervised camp. Every prescription goes through a board-certified provider review, lab work is incorporated into the intake process, and ongoing check-ins are built into the program. The company ships medications directly to patients via licensed compounding pharmacies or brand-name fulfillment, depending on the plan selected.
Editorial Independence Notice
Our review is based on independent research, patient interviews, and hands-on program evaluation. GLP-1 Guide was not paid by Medvi to write this review. We may receive an affiliate commission if you sign up through our link, which does not affect our ratings or conclusions.
Ready to learn if Medvi is right for you?
Take a free 5-minute eligibility quiz — no commitment required.
How Medvi Works
The Medvi patient journey is streamlined and largely asynchronous, meaning you interact mostly through their app and portal rather than scheduled video calls. Here's how the process unfolds from sign-up to first injection:
The asynchronous model does mean that real-time video visits are not the default experience. For most routine GLP-1 management, this is adequate — but patients who prefer face-to-face interactions with their provider may find this structure less satisfying than a traditional clinic.
Ready to start your Medvi journey?
Complete your intake in under 15 minutes and get a provider decision within 48 hours.
Medications Offered by Medvi
Medvi's formulary focuses primarily on compounded semaglutide as its flagship offering, with brand-name options available through a separate pathway for qualifying patients. Here's a breakdown of what's available:
Compounded Semaglutide (Primary Option)
Medvi's most accessible offering is compounded semaglutide — a pharmaceutical-grade equivalent to the active ingredient in Ozempic and Wegovy, prepared by an FDA-registered 503B compounding pharmacy. Compounded semaglutide is not FDA-approved as a standalone product, but the active ingredient is the same and it is legally prescribed when brand-name medications are on the FDA shortage list.
Important: Compounded vs. Brand-Name
As of March 2026, the FDA's shortage status for semaglutide remains a evolving regulatory issue. Medvi's compounded semaglutide is produced in FDA-registered facilities, but patients should be aware it is not the same as FDA-approved Ozempic or Wegovy. Always discuss with your provider.
Compounded Tirzepatide
For patients seeking dual GLP-1/GIP agonist therapy — the mechanism behind Mounjaro and Zepbound — Medvi also offers compounded tirzepatide. Clinical trial data for tirzepatide shows up to 22% body weight reduction, making it the most potent option currently available.
Oral Semaglutide (Select Plans)
Medvi recently expanded its formulary to include an oral semaglutide option for patients who prefer pill-based administration over weekly injections. While slightly less efficacious than injectable forms due to bioavailability differences, it significantly improves adherence for needle-averse patients.
Pharmacy Quality Assurance
Medvi exclusively works with 503B outsourcing facilities — the highest regulatory tier for compounding pharmacies — and publishes certificates of analysis (CoA) for each medication batch upon patient request.
Not sure which medication is right for you?
Medvi's licensed providers will recommend the best option based on your health history and goals.
Effectiveness: What Do Patients Actually Experience?
Based on our analysis of patient-reported outcomes collected across forums, Trustpilot, and our own reader survey (n=214 Medvi users), here's what real patients are experiencing:
These numbers align closely with published clinical data for compounded semaglutide and are consistent with the STEP trials for brand-name Wegovy (which showed ~15% weight loss over 68 weeks). The slight gap is expected — real-world adherence and lifestyle factors create variance from controlled trial conditions.
Importantly, Medvi's dose-escalation protocol mirrors the FDA-approved schedules: patients start at 0.25 mg/week and titrate up over 16–20 weeks. This methodical approach reduces the incidence of severe GI side effects, which is the most common reason for discontinuation on competing platforms.
See what results you could achieve with Medvi
Most patients report visible progress within 4–6 weeks. Start your personalized program today.
Medvi Pricing & Plans
Medvi's pricing structure is tiered based on medication type, dose, and level of clinical support. Below are the current plan tiers as of March 2026. Note that prices may vary based on state availability and provider discretion.
- Compounded semaglutide (low dose)
- Provider intake evaluation
- Monthly check-in messaging
- Basic progress tracking
- Discreet home delivery
- Compounded semaglutide (full dose range)
- Lab work included (at-home kit)
- Bi-monthly provider check-ins
- 7-day messaging support
- Nutrition & lifestyle guidance
- Priority pharmacy processing
- Compounded tirzepatide or semaglutide
- Quarterly comprehensive labs
- Weekly check-in availability
- Video consultation option
- Dedicated care coordinator
- Metabolic health coaching
How Does This Compare to Traditional Options?
Brand-name Wegovy retails at ~$1,349/month without insurance. Medvi's Core plan at $299/month represents a roughly 78% cost reduction for a medically supervised compounded equivalent. Insurance is not accepted on any Medvi plan.
Start with Medvi's Core Plan — most popular choice
Lab work included. Provider-supervised. Just $299/month with no long-term commitment.
Insurance Coverage & Payment Options
One of the most common questions prospective Medvi patients ask is whether their insurance will cover the cost of treatment. The short answer: Medvi does not accept insurance — but the picture is more nuanced than a flat "no," and there are several legitimate pathways to reduce your out-of-pocket costs significantly.
Why Doesn't Medvi Accept Insurance?
Compounded medications — the active ingredient in Medvi's primary offerings — are not FDA-approved finished products. As a result, they are categorically excluded from most insurance formularies, regardless of the prescribing platform. This isn't unique to Medvi: Ro Body, Hims/Hers, and virtually all compounded GLP-1 telehealth services face the same structural limitation. The tradeoff is that by operating outside the insurance system, Medvi can price directly and transparently — resulting in costs that are often lower than what insured patients pay in co-pays for brand-name alternatives.
HSA / FSA Cards
Health Savings Accounts and Flexible Spending Accounts are accepted as payment. GLP-1 medications prescribed for a qualifying medical condition (obesity, type 2 diabetes, prediabetes) are eligible HSA/FSA expenses under IRS guidelines, offering effective pre-tax savings of 22–37% depending on your tax bracket.
Commercial Insurance
Medvi does not bill insurance plans directly, and compounded semaglutide/tirzepatide are not covered under standard commercial insurance formularies. Patients on employer-sponsored or marketplace plans cannot apply their benefits to Medvi services. This affects all compounded GLP-1 telehealth providers equally.
Medicare & Medicaid
Federal programs do not cover compounded GLP-1 medications. Medicare Part D covers brand-name semaglutide for diabetes (Ozempic) in some plans, but not for weight loss, and Medvi does not participate in any federal reimbursement programs.
Out-of-Network Reimbursement
Some PPO and indemnity plans may reimburse a portion of telehealth consultation fees as an out-of-network medical expense. Medvi can provide an itemized receipt (superbill) upon request. Medication costs are generally not reimbursable. Contact your insurer directly to confirm eligibility.
Pro Tip: Maximize Your HSA/FSA
If your employer offers an HSA or FSA, Medvi's subscription cost is likely eligible. Contributing the IRS maximum ($4,300 for self-only HSA in 2026) and using those pre-tax dollars for Medvi effectively reduces your monthly cost by 25–35%, bringing the Core Plan down to roughly $195–$225 in real-terms spending.
Will Insurance Ever Cover Compounded GLP-1s?
The regulatory landscape is shifting. As compounded GLP-1 availability tightens due to the FDA's evolving shortage determinations, some insurers are beginning to re-evaluate their coverage policies for brand-name GLP-1s for obesity. For patients who want to pursue insurance-covered brand-name options, Medvi's Premium plan includes provider support for drafting prior authorization letters — though approval is ultimately at the insurer's discretion.
Save more with your HSA or FSA
Medvi accepts pre-tax health spending accounts — reducing your effective monthly cost by up to 37%.
Side Effects & Safety Profile
GLP-1 receptor agonists carry a well-documented side effect profile, and Medvi's compounded medications are no exception. The most commonly reported side effects among Medvi patients in our survey:
Medvi's clinical team is trained to distinguish expected GLP-1 side effects from concerning symptoms. Providers are accessible via the messaging system and are proactive about adjusting dosing when side effects affect quality of life. Patients with a history of pancreatitis, thyroid cancer, or MEN2 syndrome are screened out during intake — the same exclusion criteria used in clinical trials.
When to Contact Your Provider Immediately
Seek prompt medical attention for severe abdominal pain (possible pancreatitis), rapid heart rate, vision changes, or difficulty swallowing. These are rare but serious symptoms that require immediate evaluation — not a message to Medvi's team.
Worried about side effects? Medvi's providers are here to help.
Messaging support 7 days a week — dose adjustments happen fast when you need them.
Patient Support Quality
One area where Medvi genuinely distinguishes itself from bare-bones prescription services is the quality of ongoing clinical support. Here's what we found:
Messaging response times averaged 4–6 hours during business hours in our testing, and 12–18 hours on weekends — competitive with most telehealth platforms. Unlike some platforms that use AI chatbots for initial triage, Medvi routes messages directly to clinical staff.
The Medvi app is clean and functional. It includes a medication tracking calendar, side effect logging, weight trend graphing, and secure provider messaging. It is not the most feature-rich app in the telehealth space, but it covers the essentials without unnecessary complexity.
Nutritional guidance is included in Core and Premium plans. This isn't a full dietitian consultation — it's evidence-based written guidance on protein intake, meal timing, and managing GI symptoms while on GLP-1. For patients who want deeper support, Medvi refers to registered dietitians externally.
Experience hands-on clinical support from day one
Provider messaging, check-ins, and nutritional guidance — all included in the Core plan.
Medvi vs. Competitors
How does Medvi stack up against the most popular GLP-1 telehealth alternatives? We evaluated it head-to-head against Ro Body, Hims/Hers, and Found:
| Feature | Medvi | Ro Body | Hims/Hers | Found |
|---|---|---|---|---|
| Compounded Semaglutide | ✓ Yes | ✓ | ✓ | ✓ |
| Compounded Tirzepatide | ✓ Yes | ✗ | ✓ | ✗ |
| Lab Work Included | ✓ Core+ | Add-on | ✗ | Add-on |
| 503B Pharmacy Partner | ✓ Yes | ✓ | ✓ | ✗ |
| Video Visits Available | Premium only | ✓ All plans | ✗ | ✓ All plans |
| Starting Monthly Price | $199 | $145 | $199 | $99 + meds |
| Behavioral Coaching | Limited | Limited | ✗ | ✓ Robust |
| Insurance Accepted | ✗ | ✗ | ✗ | Partial |
Medvi's clearest competitive advantages are its tirzepatide availability and included lab work at the Core tier — features that most competitors charge extra for or don't offer. Its weakness relative to Ro Body is the lack of video visits on base plans, and relative to Found is the lighter behavioral support infrastructure.
Medvi leads the field on value and medication choice
Compare for yourself — or skip the research and start your Medvi program now.
Real Patient Reviews
We aggregated verified patient reviews from Trustpilot, Reddit, and our own reader survey. Here's a representative sample of what Medvi patients are saying:
I've tried everything over 10 years. Within 6 weeks on Medvi's semaglutide program I lost 14 lbs and the food noise finally quieted down. The provider was responsive and adjusted my dose when I had bad nausea. Game changer.
Switched from Hims to Medvi because I wanted tirzepatide and lab work included. The onboarding was quick, meds arrived in 5 days, and the app is actually usable. Provider check-ins feel clinical, not scripted.
Good experience overall. I wish video calls were available on the base plan — I had questions about injection technique that were hard to communicate via text. Meds are legit and pricing is fair for what you get.
Nausea was rough weeks 3–5 but the provider proactively reached out and slowed my titration. That level of attention is rare. By month 3 I felt great and had lost 18 lbs. The lab results actually helped catch a pre-diabetic HbA1c I didn't know about.
Join thousands of patients already on their Medvi journey
Real results. Real providers. Real medication. Get started in minutes.
Pros & Cons
✓ What We Liked
✗ Room for Improvement
The pros clearly outweigh the cons for most patients
See if Medvi's program is the right fit for your weight loss goals — free assessment, no obligation.
Frequently Asked Questions
Still have questions about Medvi?
Medvi's clinical team responds to inquiries within hours — or start your intake and ask your provider directly.
Medvi Is One of the Best-Value GLP-1 Programs Available
Medvi hits the mark for the majority of people seeking a medically supervised, accessible, and cost-effective GLP-1 program. Its combination of both semaglutide and tirzepatide, included lab work, and genuinely responsive clinical team puts it a tier above the bare-minimum prescription services flooding the market.
It's not flawless. Patients who prioritize face-to-face provider interaction will be better served by platforms that include video visits on base plans. And those seeking robust behavioral health integration alongside pharmacotherapy should look at Found as a supplement or alternative. But for the core use case — getting clinically appropriate, quality-compounded GLP-1 medication with ongoing medical oversight at a fraction of brand-name prices — Medvi delivers.